bupivacaine

FDA Drug Profile — EXPAREL

bupivacaine is listed in the FDA National Drug Code directory with 5 NDC codes, marketed under brand name including EXPAREL. Available dosage form: injection, suspension, liposomal.

Drug details

Generic Name
bupivacaine
Brand Names
EXPAREL
Application Number
NDA022496
Sponsor
Pacira Pharmaceuticals, Inc.
NDC Codes
5
Dosage Forms
INJECTION, SUSPENSION, LIPOSOMAL
Routes
INFILTRATION
Active Ingredients
BUPIVACAINE

Indications and Usage

1 INDICATIONS AND USAGE EXPAREL is indicated to produce postsurgical: Local analgesia via infiltration in patients aged 6 years and older Regional analgesia via an interscalene brachial plexus nerve block in adults Regional analgesia via a sciatic nerve block in the popliteal fossa in adults Regional analgesia via an adductor canal block in adults EXPAREL contains bupivacaine, an amide local anesthetic, and is indicated to produce postsurgical: Local analgesia via infiltration in patients aged 6 years and older ( 1 ). Regional analgesia via an interscalene brachial plexus nerve block in adults ( 1 ). Regional analgesia via a sciatic nerve block in the popliteal fossa in adults ( 1 ). Regional analgesia via an adductor canal block in adults ( 1 ). Limitations of Use The safety and effectiveness of EXPAREL have not been established to produce postsurgical regional analgesia via other nerve blocks besides an interscalene brachial plexus nerve block, a sciatic nerve block in the popliteal fossa, or an adductor canal block. Limitations of Use The safety and effectiveness of EXPAREL have not been established to produce postsurgical regional analgesia via other nerve blocks besides an interscalene brachial plexus nerve block, a sciatic nerve block in the popliteal fossa, or an adductor canal block.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.